Continuing Education

Jacob A. Udell Jacob A. Udell, MD, MPH, Peter Munk Cardiac Centre, Toronto General Hospital and Cardiovascular Division, Women’s College

Background: Sacubitril/valsartan (S/V) treatment is associated with reverse cardiac remodeling and reductions in biomarkers reflecting ventricular wall stress and myocardial

Peter W. Groeneveld https://orcid.org/0000-0002-7374-4292 Penn Cardiovascular Outcomes, Quality, & Evaluative Research Center, Perelman School of Medicine, University of Pennsylvania, PA.

Circulation: Heart Failure, Ahead of Print. Source link

Michelle M. Kittleson Correspondence to: Michelle M. Kittleson, MD, PhD, Division of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, 8536

Bart S. Ferket Correspondence to: Bart S. Ferket, MD, PhD, Department of Population Health Science and Policy, Institute for Healthcare

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Marketing payments from the pharmaceutical industry to physicians have come under scrutiny

Circulation: Heart Failure, Ahead of Print. Source link

Background: The effect of the new donor heart allocation system on survival following bridging to transplantation with venous-arterial extracorporeal membrane

Circulation: Heart Failure, Ahead of Print. Background:Exercise hemodynamics can differentiate heart failure with preserved ejection fraction (HFpEF) from noncardiac dyspnea.